January 1, 2016Journal of Thrombosis and ThrombolysisOpen Access

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment

View Full Paper

Ask AI

Bookmark

Population

Patients with venous thromboembolism (VTE)

Comparison

Direct oral anticoagulants including apixaban… vs Conventional therapy

Design

Guideline

Authors

ABAllison BurnettUniversity of New Mexico Hospital CMCharles E. MahanAstraZeneca (United States)SVSara R. VazquezUniversity of Utah

Discussion

Member takes

Implication

Streamlines DOAC selection, initiation, and monitoring in VTE; extends trial evidence into standardized frontline protocols.

Structured PICO

Population

Patients with venous thromboembolism (VTE)

Intervention

Direct oral anticoagulants (DOACs) including apixaban, dabigatran, edoxaban, and rivaroxaban

Comparator

Conventional therapy (rapid-acting parenteral anticoagulant overlapped with a vitamin K antagonist such as warfarin)

This consensus document provides practical clinical guidance for frontline clinicians on the appropriate patient selection, initiation, and laboratory measurement of DOACs for VTE treatment.

Cite This Study

Burnett et al. (2016) studied this question.

synapsesocial.com/papers/6a7cec210c48a91e15f02eca https://doi.org/10.1007/s11239-015-1310-7

Topics

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider